Roivant Sciences Ltd.
NASDAQ:ROIV
11.92 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 55.132 | 28.93 | 37.14 | 37.101 | 21.624 | 27.376 | 17.052 | 12.533 | 4.319 | 9.223 | 24.341 | 13.987 | 7.735 | 15.146 | 5.75 | 1.323 | 1.576 | 62.947 |
| Cost of Revenue
| 6.511 | 4.412 | 3.668 | 3.266 | 4.214 | 4.175 | 3.586 | 3.641 | 1.726 | 0.459 | 1.384 | 6.381 | 0.742 | 0.478 | 0.684 | 0.715 | 0.18 | 263.81 |
| Gross Profit
| 48.621 | 24.518 | 33.472 | 33.835 | 17.41 | 23.201 | 13.466 | 8.892 | 2.593 | 8.764 | 22.957 | 7.606 | 6.993 | 14.668 | 5.066 | 0.608 | 1.396 | -200.863 |
| Gross Profit Ratio
| 0.882 | 0.847 | 0.901 | 0.912 | 0.805 | 0.847 | 0.79 | 0.709 | 0.6 | 0.95 | 0.943 | 0.544 | 0.904 | 0.968 | 0.881 | 0.46 | 0.886 | -3.191 |
| Reseach & Development Expenses
| 133.208 | 120.902 | 123.717 | 131.984 | 125.133 | 131.857 | 125.533 | 131.995 | 135.83 | 135.077 | 153.45 | 254.259 | 78.626 | -121.778 | 202.261 | 97.409 | 58.734 | 64.23 |
| General & Administrative Expenses
| 148.519 | 197.282 | 197.282 | 0 | 156.19 | 125.51 | 168.261 | 157.663 | 149.072 | 138.973 | 115.53 | 437.776 | 82.754 | 81.148 | 61.875 | 59.74 | 57.115 | 80.625 |
| Selling & Marketing Expenses
| -2.533 | -156.19 | 0 | 0 | 156.19 | 0 | 0 | 0 | 149.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 145.986 | 169.616 | 197.282 | 164.355 | 156.19 | 125.51 | 168.261 | 157.663 | 149.072 | 138.973 | 115.53 | 437.776 | 82.754 | 81.148 | 61.875 | 59.74 | 57.115 | 80.625 |
| Other Expenses
| 116.377 | -33.061 | 25.412 | -27.464 | -49.919 | 16.779 | -42.462 | 7.591 | -42.298 | 43.195 | -21.988 | -16.837 | -4.451 | -5.531 | 1.484 | -9.391 | -19.967 | 0 |
| Operating Expenses
| 279.194 | 290.518 | 320.999 | 296.339 | 281.323 | 257.367 | 293.794 | 289.658 | 284.902 | 274.05 | 268.98 | 692.035 | 161.38 | -40.63 | 264.136 | 157.149 | 115.849 | 119.605 |
| Operating Income
| -230.573 | -266 | 5,060.883 | 276.454 | -276.413 | -234.166 | -280.328 | -280.766 | -282.309 | -265.286 | -246.023 | -684.429 | -154.387 | -540.834 | -259.07 | -156.541 | -114.453 | -82.501 |
| Operating Income Ratio
| -4.182 | -9.195 | 136.265 | 7.451 | -12.783 | -8.554 | -16.44 | -22.402 | -65.364 | -28.764 | -10.107 | -48.933 | -19.96 | -35.708 | -45.056 | -118.323 | -72.622 | -1.311 |
| Total Other Income Expenses Net
| 300.718 | -1.736 | 5,363.355 | -69.909 | -69.983 | 54.95 | -101.749 | -32.99 | -67.476 | -26.19 | -60.024 | 459.19 | 53.402 | -617.09 | -16.751 | 103.754 | 107.697 | 9.601 |
| Income Before Tax
| 70.145 | -191.453 | 5,098.337 | -327.361 | -326.093 | -179.216 | -382.077 | -313.756 | -349.785 | -291.476 | -306.047 | -225.239 | -100.985 | -563.183 | -275.821 | -52.787 | -6.756 | -72.9 |
| Income Before Tax Ratio
| 1.272 | -6.618 | 137.273 | -8.824 | -15.08 | -6.546 | -22.407 | -25.034 | -80.987 | -31.603 | -12.573 | -16.103 | -13.056 | -37.184 | -47.969 | -39.899 | -4.287 | -1.158 |
| Income Tax Expense
| 12.655 | -8.957 | 25.672 | 3.757 | 1.752 | -3.793 | 2.819 | 2.165 | 3.999 | -0.163 | 0.038 | 0.401 | 0.093 | -0.022 | -0.224 | 0.711 | 1.221 | 2.839 |
| Net Income
| 95.297 | -151.115 | 5,096.184 | -304.327 | -291.816 | -175.423 | -384.896 | -315.921 | -353.784 | -291.313 | -284.536 | -208.481 | -82.183 | -509.564 | -261.029 | -35.398 | -3.243 | -60.017 |
| Net Income Ratio
| 1.729 | -5.223 | 137.216 | -8.203 | -13.495 | -6.408 | -22.572 | -25.207 | -81.913 | -31.585 | -11.69 | -14.905 | -10.625 | -33.643 | -45.396 | -26.756 | -2.058 | -0.953 |
| EPS
| 0.13 | -0.19 | 6.37 | -0.4 | -0.38 | -0.24 | -0.54 | -0.46 | -0.51 | -0.42 | -0.41 | -0.3 | -0.12 | -0.74 | -0.38 | -0.052 | -0.005 | -0.25 |
| EPS Diluted
| 0.12 | -0.19 | 6.03 | -0.4 | -0.38 | -0.24 | -0.54 | -0.45 | -0.51 | -0.42 | -0.41 | -0.3 | -0.12 | -0.74 | -0.38 | -0.052 | -0.005 | -0.25 |
| EBITDA
| -225.69 | -210.378 | -224.777 | -270.082 | -291.278 | -203.103 | -221.041 | -267.505 | -322.626 | -195.901 | -207.987 | -1,160.456 | -212.24 | 242.135 | -240.835 | -269.686 | -242.117 | 25.323 |
| EBITDA Ratio
| -4.094 | -7.272 | -6.052 | -7.28 | -13.47 | -7.419 | -12.963 | -21.344 | -74.699 | -21.24 | -8.545 | -82.967 | -27.439 | 15.987 | -41.884 | -203.844 | -153.628 | 0.402 |